DK0984943T3 - Azacycloalkan og -alkenderivater, deres fremstilling og anvendelse - Google Patents

Azacycloalkan og -alkenderivater, deres fremstilling og anvendelse

Info

Publication number
DK0984943T3
DK0984943T3 DK98921379T DK98921379T DK0984943T3 DK 0984943 T3 DK0984943 T3 DK 0984943T3 DK 98921379 T DK98921379 T DK 98921379T DK 98921379 T DK98921379 T DK 98921379T DK 0984943 T3 DK0984943 T3 DK 0984943T3
Authority
DK
Denmark
Prior art keywords
monocyclic
aryl
heteroaryl group
alkynyl
cycloalkyl
Prior art date
Application number
DK98921379T
Other languages
Danish (da)
English (en)
Inventor
Dan Peters
Gunnar M Olsen
Simon Feldbaek Nielsen
Elsebet Ostergaard Nielsen
Original Assignee
Neurosearch As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch As filed Critical Neurosearch As
Application granted granted Critical
Publication of DK0984943T3 publication Critical patent/DK0984943T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34Tobacco-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D225/00Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
    • C07D225/02Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom not condensed with other rings

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK98921379T 1997-05-30 1998-05-29 Azacycloalkan og -alkenderivater, deres fremstilling og anvendelse DK0984943T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK62997 1997-05-30
PCT/DK1998/000226 WO1998054152A1 (en) 1997-05-30 1998-05-29 Azacyclooctane and heptane derivatives, their preparation and usein therapy

Publications (1)

Publication Number Publication Date
DK0984943T3 true DK0984943T3 (da) 2003-03-17

Family

ID=8095755

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98921379T DK0984943T3 (da) 1997-05-30 1998-05-29 Azacycloalkan og -alkenderivater, deres fremstilling og anvendelse

Country Status (12)

Country Link
US (2) US6420395B1 (de)
EP (1) EP0984943B1 (de)
JP (1) JP2002511068A (de)
CN (1) CN1124266C (de)
AT (1) ATE229509T1 (de)
AU (1) AU736547B2 (de)
CA (1) CA2289576A1 (de)
DE (1) DE69810107T2 (de)
DK (1) DK0984943T3 (de)
NZ (1) NZ500644A (de)
WO (1) WO1998054152A1 (de)
ZA (1) ZA984638B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5254616B2 (ja) 2004-09-13 2013-08-07 クロノ セラピューティクス、インコーポレイテッド 生物学的同調性(biosynchronous)経皮的薬物送達
EP2322168A1 (de) 2007-04-02 2011-05-18 Parkinson's Institute Verfahren und Zusammensetzung zur Verringerung der Nebenwirkungen von therapeutischen Behandlungen
CN102516172B (zh) * 2011-11-25 2013-09-04 中国农业大学 一种2,3,4,7-四氢-1h-氮杂卓类化合物及其制备方法与应用
US10213438B2 (en) 2014-11-18 2019-02-26 Mymd Pharmaceuticals, Inc. Alkaloid compounds for treating depression, substance addictions, and indications associated with chronic inflammation
JP2018511355A (ja) 2015-01-28 2018-04-26 クロノ セラピューティクス インコーポレイテッドChrono Therapeutics Inc. 薬剤送達方法及びシステム
US9637488B2 (en) * 2015-01-29 2017-05-02 Fuqiang Ruan Heterocyclic compounds as inhibitors of class I PI3KS
EP3565617A1 (de) 2017-01-06 2019-11-13 Chrono Therapeutics Inc. Vorrichtungen und verfahren zur transdermalen wirkstofffreisetzung
EP3801732A4 (de) 2018-05-29 2022-04-27 Morningside Venture Investments Limited Verfahren und systeme zur wirkstofffreisetzung
US12397141B2 (en) 2018-11-16 2025-08-26 Morningside Venture Investments Limited Thermally regulated transdermal drug delivery system
CN119095848A (zh) * 2022-05-05 2024-12-06 菲利普莫里斯生产公司 烟碱乙酰胆碱受体配体

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3133073A (en) 1959-12-10 1964-05-12 Sterling Drug Inc 3-aryl-1, 5-iminocycloalkanes and preparation thereof
FR1372838A (fr) 1962-10-13 1964-09-18 Basf Ag Composés bicycliques et procédé pour leur préparation
DE1174793B (de) 1962-11-13 1964-07-30 Boehringer & Soehne Gmbh Verfahren zur Herstellung von 3ª‡-Phenyl-granatanen und ihren Hydrohalogeniden
US3509161A (en) 1967-07-10 1970-04-28 Boehringer & Soehne Gmbh 3-phenyl-granatene-(2)-derivatives
US3935199A (en) * 1969-10-01 1976-01-27 Mead Johnson & Company Iminomethylindolines
IL59004A0 (en) 1978-12-30 1980-03-31 Beecham Group Ltd Substituted benzamides their preparation and pharmaceutical compositions containing them
EP0093488A3 (de) 1982-03-18 1984-05-23 Beecham Group Plc Nortropyl-Benzopyrrolinon-Verbindungen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
US5015741A (en) * 1989-10-03 1991-05-14 Philip Morris Incorporated Nicotine analogs
JP2657583B2 (ja) 1991-03-01 1997-09-24 ユニバーシテイ オブ フロリダ リサーチ ファンデーション インコーポレイテッド 神経系変性疾患の治療に対するニコチン類似体の利用
ES2153360T3 (es) 1991-05-29 2001-03-01 Abbott Lab Compuestos de isoxazol e de isotiazol que mejoran las funciones de razonamiento.
JPH07509705A (ja) 1992-08-06 1995-10-26 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー ドーパミンd3レセプター拮抗薬用5−(2−オキシフェニル)−ピロール誘導体
DE69408674T2 (de) * 1993-06-25 1998-09-10 Smithkline Beecham Plc Phenylpyrrol-derivate und ihre verwendung als dopamin d3 antagonisten
JPH11512443A (ja) 1995-09-22 1999-10-26 ノボ ノルディスク アクティーゼルスカブ 新規な置換アザ環式またはアザ二環式化合物

Also Published As

Publication number Publication date
DE69810107D1 (de) 2003-01-23
US6420395B1 (en) 2002-07-16
CN1257485A (zh) 2000-06-21
ZA984638B (en) 1998-12-11
EP0984943A1 (de) 2000-03-15
AU736547B2 (en) 2001-08-02
NZ500644A (en) 2001-08-31
US20020169156A1 (en) 2002-11-14
CN1124266C (zh) 2003-10-15
DE69810107T2 (de) 2003-08-21
WO1998054152A1 (en) 1998-12-03
US6680314B2 (en) 2004-01-20
ATE229509T1 (de) 2002-12-15
JP2002511068A (ja) 2002-04-09
AU7426298A (en) 1998-12-30
CA2289576A1 (en) 1998-12-03
EP0984943B1 (de) 2002-12-11

Similar Documents

Publication Publication Date Title
DK0984966T3 (da) 9-azabicyclo[3.3.1]non-2-en derivater, som er cholinerge ligander på nikotin-ACh receptorer
CA2289574A1 (en) 8-azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ach receptors
ATE254618T1 (de) Spiro chinuclidin-derivate, ihre herstellung und verwendung
MY114679A (en) Aroyl-piperidine derivatives
BR9610960A (pt) Derivados de 8-azabiciclo [3.2.1] oct -2- eno sua preparação e uso
DK0984943T3 (da) Azacycloalkan og -alkenderivater, deres fremstilling og anvendelse
BG102715A (bg) Нови производни на арилглицинамид, метод за получаването им и фармацевтични състави съдържащи, ги
DE69507293D1 (de) Benzamid-derivate als vasopressin-antagonisten
ATE194330T1 (de) Dihydropyridine mit kurzer wirkung
DK1034174T3 (da) Azaringetherderivater og disses anvendelse som nikotin-ACh-receptormodulatorer
EA200300044A1 (ru) Новые замещенные фталиды, способ их получения и содержащие их фармацевтические композиции
FI844333L (fi) 11-substituerade 5h,11h-pyrrolo/2,1-c/ /1,4/benzoxazepiner, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
JO2235B1 (en) Derivatives of phenyl
DK349287A (da) (2-dimethylamino-ethyl)(2-((2-methylthio-phenyl)(phenylmethyl)amino)-2-oxo-ethyl)carbamater eller urinstofderivater, fremgangsmaade til fremstilling og anvendelse som laegemiddel af saadanne forbindelser
ATE140229T1 (de) Benzoxazepinon-verfahren
DE3579189D1 (de) Heterocyclische aminoverbindungen.
ES2104688T3 (es) Un procedimiento para la preparacion de un compuesto de tio-3-cefem 3-sustituido.
BR0212932A (pt) Derivados de alquilaminopiridazinona substituìdos, processo para a preparação destes, composição farmacêutica contendo os mesmos e seus usos
DK447284A (da) Aminoderivater af 2-(n-(2,2,5,5-tetramethyl-3-pyrrolin-3-carbonyl)),deres fremstilling og anvendelse
EP0058932A3 (en) 4-aryloxy-1,2,3,4-tetrahydroisoquinolines, and intermediates, a process for preparing the same, a pharmaceutical composition containing the same and their use as medicaments
DK167580A (da) Fremgangsmaade til fremstilling af oxazolin- og thiazolinderivater
MX9710378A (es) Derivados de 4-finilaminotiazol, su proceso de preparacion y las composiciones farmaceuticas que los contienen.